Table 4

Outcomes Following Propensity Matching in the Stable, NSTEACS, and STEACS Cohorts

TRATFAOR (95% CI)p ValueC-Statistic
Stable
 30-day mortality109/36,611 (0.3)140/40,302 (0.3)0.86 (0.67–1.1)0.230.75
 MACE407/42,517 (1)369/42,517 (0.9)1.10 (0.96–1.27)0.170.61
 Bleed24/42,517 (0.1)92/42,517 (0.2)0.26 (0.17–0.41)<0.0010.76
 Access site complication54/42,002 (0.1)232/41,913 (0.6)0.23 (0.17–0.31)<0.0010.72
NSTEACS
 30-day mortality419/35,264 (1.2)607/38,443 (1.6)0.75 (0.66–0.85)<0.0010.80
 MACE493/40,193 (1.2)651/40,193 (1.6)0.75 (0.67–0.85)<0.0010.73
 Bleed64/40,187 (0.2)190/40,190 (0.5)0.34 (0.25–0.45)<0.0010.74
 Access site complication58/39,736 (0.1)278/39,743 (0.7)0.21 (0.16–0.28)<0.0010.75
STEACS
 30-day mortality703/19,711 (3.6)1,069/21,709 (4.9)0.71 (0.65–0.79)<0.0010.86
 MACE811/22,691 (3.6)1,130/22,691 (5)0.71 (0.65–0.78)<0.0010.83
 Bleed116/22,673 (0.5)232/22,677 (1)0.50 (0.40–0.62)<0.0010.74
 Access site complication24/22,292 (0.1)146/22,278 (0.7)0.16 (0.11–0.25)<0.0010.77

Values are n/n (%).

Abbreviations as in Tables 1 and 2.